Isolated arterial mucoid intimal thickening lesion in early post-transplant kidney allograft biopsies

Mineaki Kitamura1,2, Mohan Doraiswamy3, Bryce Parkinson1

  • 1Department of Pathology, Division of Renal and Transplant Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, US.

Abstract

Insights

Isolated arterial mucoid intimal thickening in kidney transplants may indicate early thrombotic microangiopathy (TMA). Prompt immunosuppression adjustments can improve outcomes, showing better graft survival than established TMA.

Area of Science:

  • Nephrology
  • Transplant Pathology
  • Immunosuppression

Background:

  • Thrombotic microangiopathy (TMA) presents with diverse kidney biopsy findings.
  • Early post-transplant biopsies may exhibit isolated arterial mucoid intimal thickening, a finding whose significance is unclear.

Purpose of the Study:

  • To determine the clinical importance of isolated arterial mucoid intimal thickening in early kidney allograft biopsies.
  • To assess the association of this finding with thrombotic microangiopathy (TMA) and patient outcomes.

Main Methods:

  • Retrospective analysis of 19 kidney biopsies with isolated arterial mucoid intimal thickening.
  • Comparison with 22 biopsies of confirmed TMA and survival analysis against delayed graft function (DGF) and no-DGF control groups.

Main Results:

  • Seven cases showed peripheral schistocytes, but no other systemic TMA features.
  • Eight patients had immunosuppression adjustments; none progressed to full TMA.
  • Graft survival in the isolated thickening group was comparable to DGF and superior to TMA groups.

Conclusions:

  • Isolated arterial mucoid intimal thickening may represent an early or mild form of TMA.
  • Immunosuppression adjustment may be warranted.
  • Excluding other TMA causes and considering donor factors are crucial.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...